MVP 2.20% 44.5¢ medical developments international limited

Another Positive Study, page-42

  1. 2,337 Posts.
    lightbulb Created with Sketch. 334
    Yep these guys running the show are the real deal, MVP will get FDA approval and until then they have the potential 24,000,000 unit sales a year in Europe alone no wonder the Chairman is having a good crack buying.

    MVP is seriously under valued with this team on the stage pulling the strings
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.